This page includes the latest FDA filings for Novavax Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | NVAX | DUNS 808837520 |
Device Company | Device | Date |
|---|---|---|
| Novavax, Inc. | Other Medication | 2024-09-29 |
| Novavax, Inc. | Other Medication | 2024-09-05 |
| Novavax, Inc. | Other Medication | 2024-07-25 |
| Novavax, Inc. | Other Medication | 2023-10-14 |
| Novavax, Inc. | Other Medication | 2023-08-05 |
| Novavax, Inc. | Other Medication | 2023-08-02 |
| Novavax, Inc. | Other Medication | 2023-06-08 |
| Novavax, Inc. | Other Medication | 2023-04-07 |
| Novavax, Inc. | Other Medication | 2023-02-19 |
| Novavax, Inc. | Other Medication | 2022-11-03 |
| Novavax, Inc. | Other Medication | 2022-09-19 |
| Novavax, Inc. | Other Medication | 2022-08-31 |
| Novavax, Inc. | Other Medication | 2022-07-29 |
| Novavax, Inc. | Other Medication | 2022-03-10 |
| Novavax, Inc. | Other Medication | 2021-05-13 |
| Novavax, Inc. | Other Medication | 2021-04-27 |
| Novavax Inc. | NOVAVAX COVID-19 Vaccine, Adjuvanted | 2021-04-23 |
| CAGE Code | 1UCZ4 | NOVAVAX, INC. CORPORATE |
| S.A.M. Registration | 1UCZ4 [808837520] | NOVAVAX, INC. |
| SEC | 0001000694 | NOVAVAX INC of DELAWARE |